Literature DB >> 2823417

An interaction of benzene metabolites reproduces the myelotoxicity observed with benzene exposure.

D A Eastmond1, M T Smith, R D Irons.   

Abstract

Benzene-induced myelotoxicity can be reproduced by the coadministration of two principal metabolites, phenol and hydroquinone. Coadministration of phenol (75 mg/kg) and hydroquinone (25-75 mg/kg) twice daily to B6C3F1 mice for 12 days resulted in a significant loss in bone marrow cellularity in a manner exhibiting a dose-response. One explanation for this potentiation is that phenol stimulates the peroxidase-dependent metabolism of hydroquinone. Addition of phenol to incubations containing horseradish peroxidase, H2O2, and hydroquinone resulted in a stimulation of both hydroquinone removal and benzoquinone formation. Stimulation occurred with phenol as low as 100 microM and with very low concentrations of horseradish peroxidase. When boiled rat liver protein was added to identical incubations containing [14C]hydroquinone, the level of radioactivity recovered as protein bound increased by 37% when phenol was added. Similar results were observed when [14C]hydroquinone was incubated in the presence of activated human leukocytes. Hydroquinone binding was increased by approximately 70% in the presence of phenol. Phenol-induced stimulation of hydroquinone metabolism and benzoquinone formation represents a likely explanation for the bone marrow suppression associated with benzene toxicity.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2823417     DOI: 10.1016/0041-008x(87)90196-7

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  33 in total

1.  Myeloperoxidase-dependent oxidation of etoposide in human myeloid progenitor CD34+ cells.

Authors:  Irina I Vlasova; Wei-Hong Feng; Julie P Goff; Angela Giorgianni; Duc Do; Susanne M Gollin; Dale W Lewis; Valerian E Kagan; Jack C Yalowich
Journal:  Mol Pharmacol       Date:  2010-11-19       Impact factor: 4.436

2.  Synergistic action of the benzene metabolite hydroquinone on myelopoietic stimulating activity of granulocyte/macrophage colony-stimulating factor in vitro.

Authors:  R D Irons; W S Stillman; D B Colagiovanni; V A Henry
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

Review 3.  The use of biomonitoring data in exposure and human health risk assessment: benzene case study.

Authors:  Scott M Arnold; Juergen Angerer; Peter J Boogaard; Michael F Hughes; Raegan B O'Lone; Steven H Robison; A Robert Schnatter
Journal:  Crit Rev Toxicol       Date:  2013-02       Impact factor: 5.635

4.  Evidence for strain-specific differences in benzene toxicity as a function of host target cell susceptibility.

Authors:  D J Neun; A Penn; C A Snyder
Journal:  Arch Toxicol       Date:  1992       Impact factor: 5.153

5.  Mortality study of employees engaged in the manufacture and use of hydroquinone.

Authors:  J W Pifer; F T Hearne; F A Swanson; J L O'Donoghue
Journal:  Int Arch Occup Environ Health       Date:  1995       Impact factor: 3.015

6.  Relationships between metabolic and non-metabolic susceptibility factors in benzene toxicity.

Authors:  David Ross; Hongfei Zhou
Journal:  Chem Biol Interact       Date:  2009-11-24       Impact factor: 5.192

7.  Mechanism of clozapine-induced agranulocytosis : current status of research and implications for drug development.

Authors:  M Pirmohamed; K Park
Journal:  CNS Drugs       Date:  1997-02       Impact factor: 5.749

Review 8.  Free radicals in chemical carcinogenesis.

Authors:  M R Clemens
Journal:  Klin Wochenschr       Date:  1991-12-15

Review 9.  The aryl hydrocarbon receptor has an important role in the regulation of hematopoiesis: implications for benzene-induced hematopoietic toxicity.

Authors:  Thomas A Gasiewicz; Kameshwar P Singh; Fanny L Casado
Journal:  Chem Biol Interact       Date:  2009-11-05       Impact factor: 5.192

Review 10.  The toxicity of benzene and its metabolism and molecular pathology in human risk assessment.

Authors:  A Yardley-Jones; D Anderson; D V Parke
Journal:  Br J Ind Med       Date:  1991-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.